Clinical Trial Update: Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of bevacizumab plus gemcitabine in advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer | Phase 2 | Status: COMPLETED